Severe placental lesions due to maternal SARS-CoV-2 infection associated to intrauterine fetal death.
COVID-19 placental lesions
Intrauterine fetal death
Pregnancy
SARS-Cov-2 infection
Journal
Human pathology
ISSN: 1532-8392
Titre abrégé: Hum Pathol
Pays: United States
ID NLM: 9421547
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
received:
22
11
2021
revised:
23
12
2021
accepted:
30
12
2021
pubmed:
8
1
2022
medline:
1
4
2022
entrez:
7
1
2022
Statut:
ppublish
Résumé
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause severe placental lesions leading rapidly to intrauterine fetal death (IUFD). From August 2020 to September 2021, in the pathology department of Toulouse Oncopole, we analyzed 50 placentas from COVID-19-positive unvaccinated mothers. The purpose of our study is to describe the clinicopathological characteristics of these placental damages and to understand the pathophysiology. Ten of them (20%) showed placental lesions with positive immunohistochemistry for SARS-CoV-2 in villous trophoblasts. In five cases (10%), we observed massive placental damage associating trophoblastic necrosis, fibrinous deposits, intervillositis, as well as extensive hemorrhagic changes due to SARS-CoV-2 infection probably responsible of IUFD by functional placental insufficiency. In five other cases, we found similar placental lesions but with a focal distribution that did not lead to IUFD but live birth. These lesions are independent of maternal clinical severity of COVID-19 infection because they occur despite mild maternal symptoms and are therefore difficult to predict. In our cases, they occurred 1-3 weeks after positive SARS-CoV-2 maternal real-time polymerase chain reaction testing and were observed in the 2nd and 3rd trimesters of pregnancies. When these lesions are focal, they do not lead to IUFD and can be involved in intrauterine growth restriction. Our findings, together with recent observations, suggest that future pregnancy guidance should include stricter pandemic precautions such as screening for a wider array of COVID-19 symptoms, enhanced ultrasound monitoring, as well as newborn medical surveillance.
Identifiants
pubmed: 34995674
pii: S0046-8177(21)00220-3
doi: 10.1016/j.humpath.2021.12.012
pmc: PMC8730375
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
46-55Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Références
Cells. 2021 Feb 10;10(2):
pubmed: 33578631
Medicina (Kaunas). 2021 Jun 28;57(7):
pubmed: 34203545
Mod Pathol. 2020 Nov;33(11):2092-2103
pubmed: 32741970
Pediatr Dev Pathol. 2020 May-Jun;23(3):177-180
pubmed: 32397896
Virchows Arch. 2021 Oct;479(4):715-728
pubmed: 33934229
J Clin Invest. 2020 Sep 1;130(9):4947-4953
pubmed: 32573498
J Neuroimmunol. 2020 Jul 14;346:577326
pubmed: 32683185
Case Rep Womens Health. 2021 Apr;30:e00289
pubmed: 33527073
Case Rep Womens Health. 2020 Jul 12;27:e00243
pubmed: 32704477
Placenta. 2021 Sep 1;112:97-104
pubmed: 34329973
Cureus. 2021 Feb 19;13(2):e13438
pubmed: 33758721
Am J Clin Pathol. 2020 Jun 8;154(1):23-32
pubmed: 32441303
Viruses. 2020 Nov 15;12(11):
pubmed: 33203131
J Stroke Cerebrovasc Dis. 2021 Mar;30(3):105536
pubmed: 33338705
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Am J Gastroenterol. 2020 Jun;115(6):942-946
pubmed: 32496741
Ultrasound Obstet Gynecol. 2021 Feb;57(2):248-256
pubmed: 32851697
Diagnostics (Basel). 2021 Jan 08;11(1):
pubmed: 33435547
Am J Obstet Gynecol. 2021 Jan;224(1):35-53.e3
pubmed: 32739398
Front Med (Lausanne). 2021 Aug 16;8:677001
pubmed: 34485327
Arch Pathol Lab Med. 2016 Jul;140(7):698-713
pubmed: 27223167
Clin Microbiol Infect. 2021 Mar;27(3):489-490
pubmed: 33022363
Placenta. 2020 Nov;101:13-29
pubmed: 32911234
Am J Obstet Gynecol MFM. 2022 Jan;4(1):100523
pubmed: 34700024
Am J Obstet Gynecol. 2020 Jul;223(1):91.e1-91.e4
pubmed: 32376317
Elife. 2020 Jul 14;9:
pubmed: 32662421